Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuzhen Wu
Institutions:
Shanghai Medical College of Fudan University,
East China University of Science and Technology,
Fudan University,
State Key Laboratory of Bioreactor Engineering
Observed institutions:
Shanghai Medical College of Fudan University,
East China University of Science and Technology,
Fudan University,
State Key Laboratory of Bioreactor Engineering
ORCID:
0009-0003-6616-653X
Observed ORCID:
0009-0003-6616-653X
OpenAlex ID:
A5034604242
Adsorption Characteristics and Enrichment of Emodin from Marine-Derived Aspergillus flavipes HN4-13 Extract by Macroporous Resin XAD-16
2022
·
Lizhi Gong
, Yuzhen Wu
, et al.
·
Marine Drugs
·
20
PDF
Hypericin-mediated photodynamic therapy enhances gemcitabine induced Capan-2 cell apoptosis via inhibiting NADPH level
2021
·
Liyun Sun
, Huoli Shang
, et al.
·
Journal of Pharmacy and Pharmacology
·
14
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
2025
·
Kaifeng Jin
, Yawei Ding
, et al.
·
Journal for ImmunoTherapy of Cancer
·
7
PDF
Phragmalin-Type Limonoids from the Fruits of Chukrasia tabularis and Their Anti-Inflammatory Activity
2023
·
Shujun Dai
, Yuzhen Wu
, et al.
·
Molecules
·
5
PDF
Discovery of Hirsutellones as Nucleolin-Targeting Natural Macrocycles for Triple-Negative Breast Cancer Treatment
2026
·
Lizhi Gong
, Jin Yang
, et al.
·
Journal of Medicinal Chemistry
·
3
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma
2026
·
Yawei Ding
, Kaifeng Jin
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
Natural killer cell infiltration elicits gender‐dependent dichotomous clinical outcomes in urothelial carcinoma
2025
·
Lingkai Zhang
, Zhaopei Liu
, et al.
·
Cancer
·
2
ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
·
Clinical Cancer Research
·
2
PDF
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma
2026
·
Jiaxing Sun
, Kaifeng Jin
, et al.
·
Cancer
·
1
TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma
2026
·
Xiaohe Su
, Kaifeng Jin
, et al.
·
British Journal of Cancer
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression
2026
·
Lingkai Zhang
, Zhaopei Liu
, et al.
·
British Journal of Cancer
Data from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
Supplementary Figure S3 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
PDF
Supplementary Figure S4 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
PDF
Supplementary Figure S1 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
PDF
Supplementary Table S1 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
Supplementary Figure S2 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
PDF
Supplementary Table S2 from ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma
2025
·
Zhaopei Liu
, Lingkai Zhang
, et al.
Show more works
View as search
Works count:
18
Citation count:
56
H-index:
4
I10-index:
2
Year
Topic
Type